Target and Its Patented Drug(s)
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T94085 | Target Info | |||
| Target Name | Retinoic acid receptor alpha (RARA) | ||||
| Synonyms | RAR-alpha; RAR alpha; Nuclear receptor subfamily 1 group B member 1; NR1B1 | ||||
| Target Type | Clinical trial Target | ||||
| Gene Name | RARA | ||||
| Biochemical Class | Nuclear hormone receptor | ||||
| UniProt ID | |||||
| Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
|---|---|---|---|---|---|
| World Intellectual Property Organization (WIPO) | |||||
| Patent ID | WO2014199905 | ||||
| Title | Medicament for Treatment of Alzheimer'S Disease. | ||||
| Abstract | A medicament for therapeutic and/or preventive treatment of Alzheimer's disease, which comprises a combination of a retinoic acid receptor (RAR) agonist such as Am80 and a retinoid X receptor (RXR) agonist such as HX630. | ||||
| Applicant(s) | Kemphys Ltd | ||||
| Representative Drug(s) | D02FAA | Drug Info | N.A. | [1] | |
| United States Patent and Trademark Office (USPTO) | |||||
| Patent ID | US20140194517 | ||||
| Title | Treatment of Graft-Versus-Host Disease Disorders Using Rar Antagonists. | ||||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.Expert Opin Ther Pat. 2016 Aug;26(8):957-71. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.